chlortetracycline

chlortetracycline is a lipid of Polyketides (PK) class. Chlortetracycline is associated with abnormalities such as Granulomatous Disease, Chronic, Infection, Ischemia, Cerebral Ischemia and Cerebral Infarction. The involved functions are known as Regulation, Binding (Molecular Function), Agent, Stimulus and Process. Chlortetracycline often locates in Protoplasm, Plasma membrane, Membrane, Cytoplasm and specific granule. The associated genes with chlortetracycline are FPR1 gene, P4HTM gene, Homologous Gene, HIST1H1C gene and Microbiome. The related lipids are Lysophosphatidylcholines, Sterols, dilauroyl lecithin, seminolipid and Total cholesterol. The related experimental models are Mouse Model.

Cross Reference

Introduction

To understand associated biological information of chlortetracycline, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with chlortetracycline?

chlortetracycline is suspected in Ischemia, Cerebral Ischemia, Cerebral Infarction, Granulomatous Disease, Chronic, Infection, Antibiotic resistant infection and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with chlortetracycline

MeSH term MeSH ID Detail
Pasteurella Infections D010326 8 associated lipids
Lymphadenitis D008199 8 associated lipids
Urethritis D014526 9 associated lipids
Tooth, Impacted D014095 9 associated lipids
Cross Infection D003428 9 associated lipids
Pneumonia D011014 10 associated lipids
Osteomyelitis D010019 10 associated lipids
Urinary Tract Infections D014552 11 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Otitis Media D010033 12 associated lipids
Campylobacter Infections D002169 13 associated lipids
Mycoplasma Infections D009175 13 associated lipids
Corneal Diseases D003316 13 associated lipids
Synovitis D013585 15 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Swine Diseases D013553 16 associated lipids
Escherichia coli Infections D004927 17 associated lipids
Bacterial Infections D001424 21 associated lipids
Hyperglycemia D006943 21 associated lipids
Myocardial Infarction D009203 21 associated lipids
Per page 10 20 50 | Total 49

PubChem Associated disorders and diseases

What pathways are associated with chlortetracycline

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with chlortetracycline?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with chlortetracycline?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with chlortetracycline?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with chlortetracycline?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with chlortetracycline?

Mouse Model

Mouse Model are used in the study 'Chlortetracycline and demeclocycline inhibit calpains and protect mouse neurons against glutamate toxicity and cerebral ischemia.' (Jiang SX et al., 2005).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with chlortetracycline

Download all related citations
Per page 10 20 50 100 | Total 4669
Authors Title Published Journal PubMed Link
WOMACK CR and KASS EH A substance in egg yolk which inhibits deterioration of aureomycin activity. 1949 Proc. Soc. Exp. Biol. Med. pmid:15400842
RODRIQUEZ J and PLOTKE F Aureomycin and its effect in early stages of syphilis; a preliminary report. 1949 J Am Med Assoc pmid:15401683
ALMKLOV JR and HANSEN AE Aureomycin in staphylococcic meningitis complicating subarachnoid hemorrhage in sickle cell anemia. 1949 Pediatrics pmid:18131828
COLLINS HS and FINLAND M Aureomycin treatment of urinary tract infections. 1949 Surg Gynecol Obstet pmid:18131957
FALLER R [Not Available]. 1949 Ther Umsch pmid:18132019
JACOBS HG and JACOBS MH Aureomycin; its use in infections of the oral cavity; a preliminary report. 1949 Oral Surg. Oral Med. Oral Pathol. pmid:18132173
LONG PH Aureomycin. 1949 Sci Mon pmid:18132296
BRALEY AE and SANDERS M Aureomycin in ocular infections; a study of its spectrum. 1949 Am. J. Ophthalmol. pmid:18132880
BAER RL and MILLER OB Aureomycin therapy of disseminated cutaneous herpes simplex; Kaposi's varicelliform eruption. 1949 J. Invest. Dermatol. pmid:18133466
BERESTON ES and CARLINER PE The treatment of a case of Kaposi's varicelliform eruption with aureomycin. 1949 J. Invest. Dermatol. pmid:18133468
DOWLING HF and LEPPER MH Aureomycin in various infections; report of 180 cases and review of the clinical literature. 1949 Med Ann Dist Columbia pmid:18133899
SCARZELLA M et al. [Select cases of typhus treated with aureomycin and chloromycetin]. 1949 Minerva Pediatr. pmid:15408405
SPINK WW and YOW EM Aureomycin; present status in the treatment of human infections. 1949 J Am Med Assoc pmid:15395553
CORDIER J [Not Available]. 1949 J Med Chir Prat pmid:15395584
COOKS C The status of aureomycin in Rocky Mountain spotted fever and common infections. 1949 Med Times pmid:15395640
NATENSHON AL Recovery from pemphigus treated with aureomycin. 1949 Med Times pmid:15395641
ROSANOVA AR and WARSZEWSKI E Skin rash from aureomycin. 1949 Med Times pmid:15395642
BENHAMOU E and DESTAING [Not Available]. 1949 Sem Hop pmid:15395754
Harvey JC et al. CLINICAL EXPERIENCE WITH AUREOMYCIN. 1949 J. Clin. Invest. pmid:16695774
FINLAND M et al. Aureomycin in the treatment of primary atypical pneumonia. 1949 N. Engl. J. Med. pmid:18109605
STEENKEN W and WOLINSKY E Tuberculostatic activity of aureomycin in vitro and in vivo. 1949 Am Rev Tuberc pmid:18110359
LONG PH The present status of polymyxin, chloromycetin and aureomycin. 1949 Am Prof Pharm pmid:18111442
LONG PH and SCHOENBACH EB The experimental and clinical use of polymyxin, chloromycetin, and aureomycin. 1949 Calif Med pmid:18112450
APPELMAN HB and HALE AS Aureomycin in dendritic keratitis; case report. 1949 J Mich State Med Soc pmid:18113957
ANIGSTEIN L et al. Aureomycin; protective effect in experimental Rocky Mountain spotted fever and typhus with particular reference to intermittent treatment. 1949 Tex. Rep. Biol. Med. pmid:18114264
DE WIT JC [Not Available]. 1949 Geneeskd Gids pmid:18143537
MEIKLEJOHN G and SHRAGG RI Aureomycin in primary atypical pneumonia; a controlled evaluation. 1949 J Am Med Assoc pmid:18143684
SCARZELLA M et al. Typhoid fever treated with aureomycin and chloramphenicol. 1949 South. Med. J. pmid:18143798
CRUICKSHANK JC The treatment of experimental infection with Brucella abortus in guineapigs, including a trial of aureomycin. 1949 Mon Bull Minist Health Public Health Lab Serv pmid:18143978
WALDEN P Aureomycin. 1949 Univ West Ont Med J pmid:18144365
FEROLA R [The aureomycin]. 1949 Pediatria (Rio) pmid:18145467
BRAINERD HD What's new in aureomycin and other antibiotics. 1949 Calif Med pmid:18145965
SCARZELLA M et al. [Not Available]. 1949 Minerva Med. pmid:18146356
BOUYQUES P [Not Available]. 1949 Paris Med pmid:18146676
WOODWARD TE Chloromycetin and aureomycin; therapeutic results. 1949 Ann. Intern. Med. pmid:18146884
GRATER WC and RIDER JA Lymphocytic choriomeningitis; treatment of two cases with aureomycin. 1949 Tex State J Med pmid:18147033
FINLAND M and FINNERTY EF Aureomycin treatment of herpes zoster. 1949 N. Engl. J. Med. pmid:15398246
WELLS EB and FINLAND M Comparative effect of aureomycin and chloromycetin on psittacosis infection in chick embryos. 1949 Proc. Soc. Exp. Biol. Med. pmid:15398312
DI GANGI FE and ROGERS CH Adsorption studies of aureomycin hydrochloride on aluminum hydroxide gel. 1949 J Am Pharm Assoc Am Pharm Assoc pmid:15398560
PRZESMYCKI F et al. [Effect of aureomycin on Rickettsia prowazeki cultured in intestine of body lice]. 1949 Med Dosw Mikrobiol pmid:14779875
KALZ F et al. Aureomycin film in topical treatment of cutaneous virus eruptions. 1949 Can Med Assoc J pmid:18136112
McVAY LV et al. Septicemia due to bacteroides; aureomycin hydrochloride therapy in two cases due to Bacteroides funduliformis. 1949 J Am Med Assoc pmid:18136177
O'LEARY PA Treatment of syphilis by oral use of aureomycin. 1949 J Okla State Med Assoc pmid:18136251
PRIGOT A and WRIGHT LT Anorectogenital lymphogranuloma venereum and granuloma inguinale treated with aureomycin. 1949 N Y State J Med pmid:18136343
GOLDMAN HM and BLOOM J The treatment of acute ulcerative necrotizing gingivitis with aureomycin. 1949 Oral Surg. Oral Med. Oral Pathol. pmid:18136989
DEBONO JE Aureomycin in undulant fever. 1949 Lancet pmid:18137353
SHWACHMAN H and CROCKER AC Aureomycin therapy in the pulmonary involvement of pancreatic fibrosis (mucoviscidosis). 1949 N. Engl. J. Med. pmid:18137397
TROUTMAN EG and FLESHER MO Aureomycin; a review. 1949 Univ South Calif Bull Sch Med pmid:18137622
DE GENNES L and BRICAIRE H [Not Available]. 1949 Presse Med pmid:18118740
LONG PH The present status of polymyxin, chloromycetin and aureomycin; experimental and clinical. 1949 Am J Pharm Sci Support Public Health pmid:18118956